Updates on Malaria Epidemiology and Prevention Strategies

被引:18
作者
Gonzalez-Sanz, Marta [1 ]
Berzosa, Pedro [2 ]
Norman, Francesca F. F. [1 ]
机构
[1] Univ Alcala, Ramon y Cajal Univ Hosp, Infect Dis Dept, CIBER Enfermedades Infecciosas,IRYCIS,Natl Referra, Madrid, Spain
[2] Carlos III Hlth Inst, Natl Ctr Trop Med, CIBER Enfermedades Infecciosas, Malaria & Neglected Trop Dis Lab, Madrid, Spain
关键词
Plasmodium spp; Malaria; COVID-19; Artemisinin resistance; Pfhrp2; 3 gene deletion; PLASMODIUM-FALCIPARUM MALARIA; MONOCLONAL-ANTIBODY; EFFICACY; METAANALYSIS; VACCINE; PHASE-3; AFRICA; HEALTH; SAFETY;
D O I
10.1007/s11908-023-00805-9
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Purpose of ReviewThe objective of this review was to provide an update on recent malaria epidemiology, both globally and in non-endemic areas, to identify the current distribution and repercussions of genetically diverse Plasmodium species and summarize recently implemented intervention and prevention tools.Recent FindingsNotable changes in malaria epidemiology have occurred in recent years, with an increase in the number of total cases and deaths globally during 2020-2021, in part attributed to the COVID-19 pandemic. The emergence of artemisinin-resistant species in new areas and the expanding distribution of parasites harbouring deletions of the pfhrp2/3 genes have been concerning. New strategies to curb the burden of this infection, such as vaccination, have been implemented in certain endemic areas and their performance is currently being evaluated.Inadequate control of malaria in endemic regions may have an effect on imported malaria and measures to prevent re-establishment of transmission in malaria-free areas are essential. Enhanced surveillance and investigation of Plasmodium spp. genetic variations will contribute to the successful diagnosis and treatment of malaria in future. Novel strategies for an integrated One Health approach to malaria control should also be strengthened.
引用
收藏
页码:131 / 139
页数:9
相关论文
共 70 条
[1]   First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children [J].
Agnandji, Selidji Todagbe ;
Lell, Bertrand ;
Soulanoudjingar, Solange Solmeheim ;
Fernandes, Jose Francisco ;
Abossolo, Beatrice Peggy ;
Conzelmann, Cornelia ;
Methogo, Barbara Gaelle Nfono Ondo ;
Doucka, Yannick ;
Flamen, Arnaud ;
Mordmueller, Benjamin ;
Issifou, Saadou ;
Kremsner, Peter Gottfried ;
Sacarlal, Jahit ;
Aide, Pedro ;
Lanaspa, Miguel ;
Aponte, John J. ;
Nhamuave, Arlindo ;
Quelhas, Diana ;
Bassat, Quique ;
Mandjate, Sofia ;
Macete, Eusebio ;
Alonso, Pedro ;
Abdulla, Salim ;
Salim, Nahya ;
Juma, Omar ;
Shomari, Mwanajaa ;
Shubis, Kafuruki ;
Machera, Francisca ;
Hamad, Ali Said ;
Minja, Rose ;
Mpina, Maxmillian ;
Mtoro, Ali ;
Sykes, Alma ;
Ahmed, Saumu ;
Urassa, Alwisa Martin ;
Ali, Ali Mohammed ;
Mwangoka, Grace ;
Tanner, Marcel ;
Tinto, Halidou ;
D'Alessandro, Umberto ;
Sorgho, Hermann ;
Valea, Innocent ;
Tahita, Marc Christian ;
Kabore, William ;
Ouedraogo, Sayouba ;
Sandrine, Yara ;
Guiguemde, Robert Tinga ;
Ouedraogo, Jean Bosco ;
Hamel, Mary J. ;
Kariuki, Simon .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (20) :1863-1875
[2]  
[Anonymous], 2017, MASS DRUG ADM FALCIP
[3]  
[Anonymous], 2021, WHO recommends groundbreaking malaria vaccine for children at risk
[4]  
[Anonymous], MALARIA VACCINE IMPL
[5]   Impact of the Mass Drug Administration for malaria in response to the Ebola outbreak in Sierra Leone [J].
Aregawi, Maru ;
Smith, Samuel J. ;
Sillah-Kanu, Musa ;
Seppeh, John ;
Kamara, Anitta R. Y. ;
Williams, Ryan O. ;
Aponte, John J. ;
Bosman, Andrea ;
Alonso, Pedro .
MALARIA JOURNAL, 2016, 15
[6]   A molecular marker of artemisinin-resistant Plasmodium falciparum malaria [J].
Ariey, Frederic ;
Witkowski, Benoit ;
Amaratunga, Chanaki ;
Beghain, Johann ;
Langlois, Anne-Claire ;
Khim, Nimol ;
Kim, Saorin ;
Duru, Valentine ;
Bouchier, Christiane ;
Ma, Laurence ;
Lim, Pharath ;
Leang, Rithea ;
Duong, Socheat ;
Sreng, Sokunthea ;
Suon, Seila ;
Chuor, Char Meng ;
Bout, Denis Mey ;
Menard, Sandie ;
Rogers, William O. ;
Genton, Blaise ;
Fandeur, Thierry ;
Miotto, Olivo ;
Ringwald, Pascal ;
Le Bras, Jacques ;
Berry, Antoine ;
Barale, Jean-Christophe ;
Fairhurst, Rick M. ;
Benoit-Vical, Franoise ;
Mercereau-Puijalon, Odile ;
Menard, Didier .
NATURE, 2014, 505 (7481) :50-+
[7]   Source identification of autochthonous-introduced Plasmodium vivax Malaria, Spain [J].
Barrado, Laura ;
Ezpeleta, Carmen ;
Miguel Rubio, Jose ;
Martin, Carmen ;
Manuel Azcona, Jose ;
Arteaga, Miren ;
Beristain, Xabier ;
Navascues, Ana ;
Ongay, Eva ;
Castilla, Jesus .
INFECTION, 2017, 45 (01) :111-114
[8]   Optimal mode for delivery of seasonal malaria chemoprevention in Ouelessebougou, Mali: A cluster randomized trial [J].
Barry, Amadou ;
Issiaka, Djibrilla ;
Traore, Tiangoua ;
Mahamar, Almahamoudou ;
Diarra, Boubacar ;
Sagara, Issaka ;
Kone, Diakalia ;
Doumbo, Ogobara K. ;
Duffy, Patrick ;
Fried, Michel ;
Dicko, Alassane .
PLOS ONE, 2018, 13 (03)
[9]   Efficacy of RTS,S malaria vaccines: individual-participant pooled analysis of phase 2 data [J].
Bejon, Philip ;
White, Michael T. ;
Olotu, Ally ;
Bojang, Kalif ;
Lusingu, John P. A. ;
Salim, Nahya ;
Otsyula, Nekoye N. ;
Agnandji, Selidji T. ;
Asante, Kwaku Poku ;
Owusu-Agyei, Seth ;
Abdulla, Salim ;
Ghani, Azra C. .
LANCET INFECTIOUS DISEASES, 2013, 13 (04) :319-327
[10]   Major Threat to Malaria Control Programs by Plasmodium falciparum Lacking Histidine-Rich Protein 2, Eritrea [J].
Berhane, Araia ;
Anderson, Karen ;
Mihreteab, Selam ;
Gresty, Karryn ;
Rogier, Eric ;
Mohamed, Salih ;
Hagos, Filmon ;
Embaye, Ghirmay ;
Chinorumba, Anderson ;
Zehaie, Assefash ;
Dowd, Simone ;
Waters, Norman C. ;
Gatton, Michelle L. ;
Udhayakumar, Venkatachalam ;
Cheng, Qin ;
Cunningham, Jane .
EMERGING INFECTIOUS DISEASES, 2018, 24 (03) :462-470